首页 | 本学科首页   官方微博 | 高级检索  
     

抑制c-FLIP_L表达增强rhTRAIL蛋白杀伤肺癌A549细胞的研究
引用本文:谭岩,刘磊,方艳秋,蒋永兴. 抑制c-FLIP_L表达增强rhTRAIL蛋白杀伤肺癌A549细胞的研究[J]. 中国免疫学杂志, 2012, 0(10): 890-893
作者姓名:谭岩  刘磊  方艳秋  蒋永兴
作者单位:吉林省人民医院医学诊治实验中心;哈尔滨医科大学
基金项目:吉林省科技厅国际合作项目(20070729-2);吉林省卫生厅项目(20082036)的资助
摘    要:目的:探讨抑制c-FLIPL表达增强rhTRAIL蛋白杀伤肺癌A549细胞株的可行性。方法:构建c-FLIPL序列特异性siRNAs表达载体并转染A549细胞抑制c-FLIPL基因表达,化学抑制剂他莫昔芬抑制c-FLIPL蛋白表达。RT-PCR和Western blot法检测c-FLIPL的mRNA和蛋白表达的变化。Western blot法检测caspase-8的活化情况。流式细胞仪检测A549细胞凋亡率,MTT法检测联合应用RNAi+rhTRAIL和他莫昔芬+rhTRAIL对A549细胞的杀伤活性。结果:特异性siRNA片段能显著降低A549细胞中c-FLIPL的mRNA水平和蛋白水平。他莫昔芬可以显著抑制c-FLIPL蛋白的表达。两者均可以实现caspase-8的活化,并促进rhTRAIL对A549细胞诱导凋亡作用,凋亡率从2.52%提高到64.5%和59.2%(P<0.05),他莫昔芬和siRNA均可显著促进rhTRAIL蛋白对A549细胞的增殖抑制作用,抑制率分别提高到73.2%和69.5%(P<0.05)。结论:靶向抑制FLIP蛋白表达能增加A549细胞对rhTRAIL诱导细胞凋亡的敏感性,有利于促进rhTRAIL蛋白在治疗NSCLC方面的研究应用。

关 键 词:重组TRAIL蛋白  凋亡抑制基因FLIP  A549细胞株  非小细胞肺癌

Inhibition of c-FLIP_L enhance rhTRAIL-based therapies for A549 cells
TAN Yan,LIU Lei,FANG Yan-Qiu,JIANG Yong-Xing. Inhibition of c-FLIP_L enhance rhTRAIL-based therapies for A549 cells[J]. Chinese Journal of Immunology, 2012, 0(10): 890-893
Authors:TAN Yan  LIU Lei  FANG Yan-Qiu  JIANG Yong-Xing
Affiliation:.Department of Cancer Biotherapy,Jilin Province People′s Hospital,Changchun 130021,China
Abstract:Objective:To investigate the possibility of enhanced killing activity of rhTRAIL to A549 cells by inhibition of c-FLIPL activity.Methods:siRNAs specific for c-FLIPL sequence and chemical inhibitor tamoxifen were added to inhibit the expression and activity of c-FLIPL and then the application of rhTRAIL protein further killed A549 cells.Caspase-8 was detected by Western blot method.The apoptotic rate of A549 cells was examined by FACS.Cell cytotoxicity activity was detected by MTT assay.Results:Short siRNAs targeting FLIP down-regulated the mRNA and the protein level of c-FLIPL.Tamoxifen inhibited the protein level of c-FLIPL.c-FLIPL-siRNA and tamoxifen may all induce the activity of caspase-8 and promote apoptosis rate of A549 cells to 64.5% and 59.2%.A significant reduction of the rate of cell proliferation was observed and inhibition rate was 73.2% and 69.5%(P<0.05).Conclusion:Inhibition of c-FLIPL protein increases the sensitivity of the A549 cell to rhTRAIL and is conducive to the promotion of rhTRAIL protein in the treatment of NSCLC applications.
Keywords:TRAIL  FLIP  A549 cells  NSCLC
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号